Rockwell Medical, Inc.
Rockwell Medical, Inc. RMTI Peers
See (RMTI) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RMTI | $1.17 | -2.10% | 44.3M | -129.50 | -$0.01 | N/A |
| ZTS | $155.33 | -1.86% | 70.7B | 28.46 | $5.58 | +1.17% |
| TAK | $14.69 | -2.91% | 46.7B | 64.46 | $0.23 | +3.97% |
| HLN | $9.97 | -0.85% | 45.4B | 23.49 | $0.43 | +1.66% |
| TEVA | $16.33 | -2.30% | 18.9B | -14.37 | -$1.15 | N/A |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| NBIX | $133.95 | +0.33% | 13.4B | 45.73 | $2.95 | N/A |
| RDY | $14.51 | -1.69% | 12.2B | 18.59 | $0.79 | +0.65% |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $9.16 | -0.81% | 10.9B | -2.91 | -$3.18 | +6.47% |
Stock Comparison
RMTI vs ZTS Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ZTS has a market cap of 70.7B. Regarding current trading prices, RMTI is priced at $1.17, while ZTS trades at $155.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ZTS's P/E ratio is 28.46. In terms of profitability, RMTI's ROE is -0.01%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, RMTI is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TAK Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TAK has a market cap of 46.7B. Regarding current trading prices, RMTI is priced at $1.17, while TAK trades at $14.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TAK's P/E ratio is 64.46. In terms of profitability, RMTI's ROE is -0.01%, compared to TAK's ROE of +0.04%. Regarding short-term risk, RMTI is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs HLN Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, HLN has a market cap of 45.4B. Regarding current trading prices, RMTI is priced at $1.17, while HLN trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas HLN's P/E ratio is 23.49. In terms of profitability, RMTI's ROE is -0.01%, compared to HLN's ROE of +0.09%. Regarding short-term risk, RMTI is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TEVA Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TEVA has a market cap of 18.9B. Regarding current trading prices, RMTI is priced at $1.17, while TEVA trades at $16.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TEVA's P/E ratio is -14.37. In terms of profitability, RMTI's ROE is -0.01%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, RMTI is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ITCI Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, RMTI is priced at $1.17, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ITCI's P/E ratio is -180.64. In terms of profitability, RMTI's ROE is -0.01%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, RMTI is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs NBIX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, NBIX has a market cap of 13.4B. Regarding current trading prices, RMTI is priced at $1.17, while NBIX trades at $133.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas NBIX's P/E ratio is 45.73. In terms of profitability, RMTI's ROE is -0.01%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, RMTI is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs RDY Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, RDY has a market cap of 12.2B. Regarding current trading prices, RMTI is priced at $1.17, while RDY trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas RDY's P/E ratio is 18.59. In terms of profitability, RMTI's ROE is -0.01%, compared to RDY's ROE of +0.18%. Regarding short-term risk, RMTI is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs CTLT Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, RMTI is priced at $1.17, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas CTLT's P/E ratio is -27.84. In terms of profitability, RMTI's ROE is -0.01%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, RMTI is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs VTRS Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, VTRS has a market cap of 10.9B. Regarding current trading prices, RMTI is priced at $1.17, while VTRS trades at $9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas VTRS's P/E ratio is -2.91. In terms of profitability, RMTI's ROE is -0.01%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, RMTI is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs RGC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, RGC has a market cap of 8.2B. Regarding current trading prices, RMTI is priced at $1.17, while RGC trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas RGC's P/E ratio is -1656.50. In terms of profitability, RMTI's ROE is -0.01%, compared to RGC's ROE of -0.25%. Regarding short-term risk, RMTI is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs ELAN Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ELAN has a market cap of 7.5B. Regarding current trading prices, RMTI is priced at $1.17, while ELAN trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ELAN's P/E ratio is 20.07. In terms of profitability, RMTI's ROE is -0.01%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, RMTI is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs LNTH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, LNTH has a market cap of 5.8B. Regarding current trading prices, RMTI is priced at $1.17, while LNTH trades at $81.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas LNTH's P/E ratio is 22.97. In terms of profitability, RMTI's ROE is -0.01%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, RMTI is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs AMRX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, AMRX has a market cap of 3.9B. Regarding current trading prices, RMTI is priced at $1.17, while AMRX trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas AMRX's P/E ratio is -210.00. In terms of profitability, RMTI's ROE is -0.01%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, RMTI is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs PRGO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, PRGO has a market cap of 3.7B. Regarding current trading prices, RMTI is priced at $1.17, while PRGO trades at $27.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas PRGO's P/E ratio is -22.72. In terms of profitability, RMTI's ROE is -0.01%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, RMTI is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs HCM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, HCM has a market cap of 2.8B. Regarding current trading prices, RMTI is priced at $1.17, while HCM trades at $16.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas HCM's P/E ratio is 80.25. In terms of profitability, RMTI's ROE is -0.01%, compared to HCM's ROE of +0.05%. Regarding short-term risk, RMTI is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ALVOW Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ALVOW has a market cap of 2.6B. Regarding current trading prices, RMTI is priced at $1.17, while ALVOW trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ALVOW's P/E ratio is N/A. In terms of profitability, RMTI's ROE is -0.01%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, RMTI is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs ALVO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ALVO has a market cap of 2.6B. Regarding current trading prices, RMTI is priced at $1.17, while ALVO trades at $8.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ALVO's P/E ratio is 23.62. In terms of profitability, RMTI's ROE is -0.01%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, RMTI is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs BHC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, BHC has a market cap of 2.5B. Regarding current trading prices, RMTI is priced at $1.17, while BHC trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas BHC's P/E ratio is -55.25. In terms of profitability, RMTI's ROE is -0.01%, compared to BHC's ROE of +0.05%. Regarding short-term risk, RMTI is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs DCPH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, RMTI is priced at $1.17, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas DCPH's P/E ratio is -11.58. In terms of profitability, RMTI's ROE is -0.01%, compared to DCPH's ROE of -0.28%. Regarding short-term risk, RMTI is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs INDV Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, INDV has a market cap of 1.9B. Regarding current trading prices, RMTI is priced at $1.17, while INDV trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas INDV's P/E ratio is -307.40. In terms of profitability, RMTI's ROE is -0.01%, compared to INDV's ROE of -0.01%. Regarding short-term risk, RMTI is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs EMBCV Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, RMTI is priced at $1.17, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EMBCV's P/E ratio is N/A. In terms of profitability, RMTI's ROE is -0.01%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, RMTI is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs SUPN Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SUPN has a market cap of 1.9B. Regarding current trading prices, RMTI is priced at $1.17, while SUPN trades at $33.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SUPN's P/E ratio is 29.86. In terms of profitability, RMTI's ROE is -0.01%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, RMTI is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs BGM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, BGM has a market cap of 1.7B. Regarding current trading prices, RMTI is priced at $1.17, while BGM trades at $9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas BGM's P/E ratio is -47.52. In terms of profitability, RMTI's ROE is -0.01%, compared to BGM's ROE of -0.03%. Regarding short-term risk, RMTI is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TARO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, RMTI is priced at $1.17, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TARO's P/E ratio is 30.05. In terms of profitability, RMTI's ROE is -0.01%, compared to TARO's ROE of +0.02%. Regarding short-term risk, RMTI is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs EVO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EVO has a market cap of 1.5B. Regarding current trading prices, RMTI is priced at $1.17, while EVO trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EVO's P/E ratio is -6.04. In terms of profitability, RMTI's ROE is -0.01%, compared to EVO's ROE of -0.22%. Regarding short-term risk, RMTI is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ANIP Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ANIP has a market cap of 1.4B. Regarding current trading prices, RMTI is priced at $1.17, while ANIP trades at $64.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ANIP's P/E ratio is -56.05. In terms of profitability, RMTI's ROE is -0.01%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, RMTI is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs DVAX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, DVAX has a market cap of 1.3B. Regarding current trading prices, RMTI is priced at $1.17, while DVAX trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas DVAX's P/E ratio is -21.78. In terms of profitability, RMTI's ROE is -0.01%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, RMTI is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs PAHC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, PAHC has a market cap of 1.3B. Regarding current trading prices, RMTI is priced at $1.17, while PAHC trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas PAHC's P/E ratio is 39.90. In terms of profitability, RMTI's ROE is -0.01%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, RMTI is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs FLXN Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, FLXN has a market cap of 1.3B. Regarding current trading prices, RMTI is priced at $1.17, while FLXN trades at $25.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas FLXN's P/E ratio is N/A. In terms of profitability, RMTI's ROE is -0.01%, compared to FLXN's ROE of +6.19%. Regarding short-term risk, RMTI is more volatile compared to FLXN. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs HROW Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, HROW has a market cap of 1.2B. Regarding current trading prices, RMTI is priced at $1.17, while HROW trades at $35.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas HROW's P/E ratio is -51.38. In terms of profitability, RMTI's ROE is -0.01%, compared to HROW's ROE of -0.36%. Regarding short-term risk, RMTI is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs PCRX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, PCRX has a market cap of 1.1B. Regarding current trading prices, RMTI is priced at $1.17, while PCRX trades at $23.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas PCRX's P/E ratio is -10.59. In terms of profitability, RMTI's ROE is -0.01%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, RMTI is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs COLL Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, COLL has a market cap of 1.1B. Regarding current trading prices, RMTI is priced at $1.17, while COLL trades at $32.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas COLL's P/E ratio is 27.06. In terms of profitability, RMTI's ROE is -0.01%, compared to COLL's ROE of +0.19%. Regarding short-term risk, RMTI is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs AMPH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, AMPH has a market cap of 1B. Regarding current trading prices, RMTI is priced at $1.17, while AMPH trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas AMPH's P/E ratio is 8.05. In terms of profitability, RMTI's ROE is -0.01%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, RMTI is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs AVDL Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, AVDL has a market cap of 947.6M. Regarding current trading prices, RMTI is priced at $1.17, while AVDL trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas AVDL's P/E ratio is -37.62. In terms of profitability, RMTI's ROE is -0.01%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, RMTI is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs PETQ Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, RMTI is priced at $1.17, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas PETQ's P/E ratio is 83.73. In terms of profitability, RMTI's ROE is -0.01%, compared to PETQ's ROE of +0.05%. Regarding short-term risk, RMTI is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs CRON Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, CRON has a market cap of 811.3M. Regarding current trading prices, RMTI is priced at $1.17, while CRON trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas CRON's P/E ratio is 15.04. In terms of profitability, RMTI's ROE is -0.01%, compared to CRON's ROE of +0.05%. Regarding short-term risk, RMTI is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TLRY Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TLRY has a market cap of 662.4M. Regarding current trading prices, RMTI is priced at $1.17, while TLRY trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TLRY's P/E ratio is -0.58. In terms of profitability, RMTI's ROE is -0.01%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, RMTI is more volatile compared to TLRY. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs EMBC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EMBC has a market cap of 627.6M. Regarding current trading prices, RMTI is priced at $1.17, while EMBC trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EMBC's P/E ratio is 12.07. In terms of profitability, RMTI's ROE is -0.01%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, RMTI is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs EOLS Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EOLS has a market cap of 626.7M. Regarding current trading prices, RMTI is priced at $1.17, while EOLS trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EOLS's P/E ratio is -10.92. In terms of profitability, RMTI's ROE is -0.01%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, RMTI is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs BDSI Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, RMTI is priced at $1.17, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas BDSI's P/E ratio is 6.82. In terms of profitability, RMTI's ROE is -0.01%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, RMTI is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ORGO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ORGO has a market cap of 558M. Regarding current trading prices, RMTI is priced at $1.17, while ORGO trades at $4.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ORGO's P/E ratio is -27.49. In terms of profitability, RMTI's ROE is -0.01%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, RMTI is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs SIGA Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SIGA has a market cap of 493.7M. Regarding current trading prices, RMTI is priced at $1.17, while SIGA trades at $6.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SIGA's P/E ratio is 10.31. In terms of profitability, RMTI's ROE is -0.01%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, RMTI is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs KMDA Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, KMDA has a market cap of 461.2M. Regarding current trading prices, RMTI is priced at $1.17, while KMDA trades at $7.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas KMDA's P/E ratio is 28.64. In terms of profitability, RMTI's ROE is -0.01%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, RMTI is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs AQST Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, AQST has a market cap of 401.2M. Regarding current trading prices, RMTI is priced at $1.17, while AQST trades at $4.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas AQST's P/E ratio is -6.96. In terms of profitability, RMTI's ROE is -0.01%, compared to AQST's ROE of +1.07%. Regarding short-term risk, RMTI is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs EBS Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EBS has a market cap of 397.3M. Regarding current trading prices, RMTI is priced at $1.17, while EBS trades at $7.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EBS's P/E ratio is -2.84. In terms of profitability, RMTI's ROE is -0.01%, compared to EBS's ROE of -0.27%. Regarding short-term risk, RMTI is more volatile compared to EBS. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs SNDL Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SNDL has a market cap of 364.1M. Regarding current trading prices, RMTI is priced at $1.17, while SNDL trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SNDL's P/E ratio is -4.72. In terms of profitability, RMTI's ROE is -0.01%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, RMTI is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs LFCR Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, LFCR has a market cap of 325.3M. Regarding current trading prices, RMTI is priced at $1.17, while LFCR trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas LFCR's P/E ratio is -5.98. In terms of profitability, RMTI's ROE is -0.01%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, RMTI is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ZYBT Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ZYBT has a market cap of 317M. Regarding current trading prices, RMTI is priced at $1.17, while ZYBT trades at $5.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ZYBT's P/E ratio is 111.50. In terms of profitability, RMTI's ROE is -0.01%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, RMTI is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs ALIM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, RMTI is priced at $1.17, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ALIM's P/E ratio is 5.28. In terms of profitability, RMTI's ROE is -0.01%, compared to ALIM's ROE of -0.32%. Regarding short-term risk, RMTI is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TKNO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TKNO has a market cap of 277.9M. Regarding current trading prices, RMTI is priced at $1.17, while TKNO trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TKNO's P/E ratio is -11.82. In terms of profitability, RMTI's ROE is -0.01%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, RMTI is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ACB Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ACB has a market cap of 264.1M. Regarding current trading prices, RMTI is priced at $1.17, while ACB trades at $4.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ACB's P/E ratio is 21.34. In terms of profitability, RMTI's ROE is -0.01%, compared to ACB's ROE of +0.00%. Regarding short-term risk, RMTI is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs LNDC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, RMTI is priced at $1.17, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas LNDC's P/E ratio is -4.04. In terms of profitability, RMTI's ROE is -0.01%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, RMTI is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs CGC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, CGC has a market cap of 246.1M. Regarding current trading prices, RMTI is priced at $1.17, while CGC trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas CGC's P/E ratio is -0.29. In terms of profitability, RMTI's ROE is -0.01%, compared to CGC's ROE of -1.13%. Regarding short-term risk, RMTI is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ESPR Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ESPR has a market cap of 245.8M. Regarding current trading prices, RMTI is priced at $1.17, while ESPR trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ESPR's P/E ratio is -1.46. In terms of profitability, RMTI's ROE is -0.01%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, RMTI is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TYHT Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, RMTI is priced at $1.17, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TYHT's P/E ratio is -1.61. In terms of profitability, RMTI's ROE is -0.01%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, RMTI is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs OGI Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, OGI has a market cap of 196.1M. Regarding current trading prices, RMTI is priced at $1.17, while OGI trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas OGI's P/E ratio is 11.27. In terms of profitability, RMTI's ROE is -0.01%, compared to OGI's ROE of +0.05%. Regarding short-term risk, RMTI is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs SXTC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SXTC has a market cap of 193.8M. Regarding current trading prices, RMTI is priced at $1.17, while SXTC trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SXTC's P/E ratio is 0.01. In terms of profitability, RMTI's ROE is -0.01%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, RMTI is more volatile compared to SXTC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs REPH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, RMTI is priced at $1.17, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas REPH's P/E ratio is -8.04. In terms of profitability, RMTI's ROE is -0.01%, compared to REPH's ROE of -0.22%. Regarding short-term risk, RMTI is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs DERM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, DERM has a market cap of 168.5M. Regarding current trading prices, RMTI is priced at $1.17, while DERM trades at $7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas DERM's P/E ratio is -19.55. In terms of profitability, RMTI's ROE is -0.01%, compared to DERM's ROE of -0.52%. Regarding short-term risk, RMTI is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs BIOA Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, BIOA has a market cap of 168M. Regarding current trading prices, RMTI is priced at $1.17, while BIOA trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas BIOA's P/E ratio is -2.37. In terms of profitability, RMTI's ROE is -0.01%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, RMTI is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs THTX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, THTX has a market cap of 144.8M. Regarding current trading prices, RMTI is priced at $1.17, while THTX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas THTX's P/E ratio is -16.58. In terms of profitability, RMTI's ROE is -0.01%, compared to THTX's ROE of +0.16%. Regarding short-term risk, RMTI is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs IRWD Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, IRWD has a market cap of 126.4M. Regarding current trading prices, RMTI is priced at $1.17, while IRWD trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas IRWD's P/E ratio is -4.11. In terms of profitability, RMTI's ROE is -0.01%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, RMTI is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs SCTL Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, RMTI is priced at $1.17, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SCTL's P/E ratio is -7.86. In terms of profitability, RMTI's ROE is -0.01%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, RMTI is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs PROC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, PROC has a market cap of 114M. Regarding current trading prices, RMTI is priced at $1.17, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas PROC's P/E ratio is 1.53. In terms of profitability, RMTI's ROE is -0.01%, compared to PROC's ROE of -2.22%. Regarding short-term risk, RMTI is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs CRDL Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, CRDL has a market cap of 112.4M. Regarding current trading prices, RMTI is priced at $1.17, while CRDL trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas CRDL's P/E ratio is -4.00. In terms of profitability, RMTI's ROE is -0.01%, compared to CRDL's ROE of -2.10%. Regarding short-term risk, RMTI is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs OPTN Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, RMTI is priced at $1.17, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas OPTN's P/E ratio is -4.42. In terms of profitability, RMTI's ROE is -0.01%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, RMTI is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ZOM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, RMTI is priced at $1.17, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ZOM's P/E ratio is -1.62. In terms of profitability, RMTI's ROE is -0.01%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, RMTI is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs GRVI Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, RMTI is priced at $1.17, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas GRVI's P/E ratio is 26.05. In terms of profitability, RMTI's ROE is -0.01%, compared to GRVI's ROE of +0.28%. Regarding short-term risk, RMTI is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs INCR Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, INCR has a market cap of 76.9M. Regarding current trading prices, RMTI is priced at $1.17, while INCR trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas INCR's P/E ratio is -3.79. In terms of profitability, RMTI's ROE is -0.01%, compared to INCR's ROE of -0.07%. Regarding short-term risk, RMTI is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ZYNE Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, RMTI is priced at $1.17, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, RMTI's ROE is -0.01%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, RMTI is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ASRT Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ASRT has a market cap of 68M. Regarding current trading prices, RMTI is priced at $1.17, while ASRT trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ASRT's P/E ratio is -2.22. In terms of profitability, RMTI's ROE is -0.01%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, RMTI is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs SSIC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, RMTI is priced at $1.17, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SSIC's P/E ratio is 11.93. In terms of profitability, RMTI's ROE is -0.01%, compared to SSIC's ROE of +0.09%. Regarding short-term risk, RMTI is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs VLNS Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, RMTI is priced at $1.17, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas VLNS's P/E ratio is -1.03. In terms of profitability, RMTI's ROE is -0.01%, compared to VLNS's ROE of N/A. Regarding short-term risk, RMTI is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs QNTM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, QNTM has a market cap of 55.3M. Regarding current trading prices, RMTI is priced at $1.17, while QNTM trades at $18.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas QNTM's P/E ratio is -1.44. In terms of profitability, RMTI's ROE is -0.01%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, RMTI is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs JUPW Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, RMTI is priced at $1.17, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas JUPW's P/E ratio is -2.41. In terms of profitability, RMTI's ROE is -0.01%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, RMTI is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs CPIX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, CPIX has a market cap of 48.9M. Regarding current trading prices, RMTI is priced at $1.17, while CPIX trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas CPIX's P/E ratio is -13.62. In terms of profitability, RMTI's ROE is -0.01%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, RMTI is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs EGRX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EGRX has a market cap of 46M. Regarding current trading prices, RMTI is priced at $1.17, while EGRX trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EGRX's P/E ratio is 4.18. In terms of profitability, RMTI's ROE is -0.01%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, RMTI is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs KALA Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, KALA has a market cap of 44.5M. Regarding current trading prices, RMTI is priced at $1.17, while KALA trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas KALA's P/E ratio is -0.94. In terms of profitability, RMTI's ROE is -0.01%, compared to KALA's ROE of -3.69%. Regarding short-term risk, RMTI is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs QLI Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, RMTI is priced at $1.17, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas QLI's P/E ratio is -4.92. In terms of profitability, RMTI's ROE is -0.01%, compared to QLI's ROE of -0.16%. Regarding short-term risk, RMTI is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs HEXO Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, RMTI is priced at $1.17, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas HEXO's P/E ratio is -0.26. In terms of profitability, RMTI's ROE is -0.01%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, RMTI is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs SCYX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SCYX has a market cap of 27.3M. Regarding current trading prices, RMTI is priced at $1.17, while SCYX trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SCYX's P/E ratio is -1.25. In terms of profitability, RMTI's ROE is -0.01%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, RMTI is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs CYTH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, RMTI is priced at $1.17, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas CYTH's P/E ratio is -0.80. In terms of profitability, RMTI's ROE is -0.01%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, RMTI is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs IXHL Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, IXHL has a market cap of 20.8M. Regarding current trading prices, RMTI is priced at $1.17, while IXHL trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas IXHL's P/E ratio is -0.18. In terms of profitability, RMTI's ROE is -0.01%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, RMTI is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs DRRX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, DRRX has a market cap of 19.1M. Regarding current trading prices, RMTI is priced at $1.17, while DRRX trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas DRRX's P/E ratio is -1.28. In terms of profitability, RMTI's ROE is -0.01%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, RMTI is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs GELS Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, GELS has a market cap of 17.8M. Regarding current trading prices, RMTI is priced at $1.17, while GELS trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas GELS's P/E ratio is -7.87. In terms of profitability, RMTI's ROE is -0.01%, compared to GELS's ROE of -0.07%. Regarding short-term risk, RMTI is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs PRPH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, PRPH has a market cap of 17.8M. Regarding current trading prices, RMTI is priced at $1.17, while PRPH trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas PRPH's P/E ratio is -0.19. In terms of profitability, RMTI's ROE is -0.01%, compared to PRPH's ROE of -1.65%. Regarding short-term risk, RMTI is more volatile compared to PRPH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs FLGC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, FLGC has a market cap of 16M. Regarding current trading prices, RMTI is priced at $1.17, while FLGC trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas FLGC's P/E ratio is -0.74. In terms of profitability, RMTI's ROE is -0.01%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, RMTI is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs ACRX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, RMTI is priced at $1.17, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas ACRX's P/E ratio is -0.31. In terms of profitability, RMTI's ROE is -0.01%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, RMTI is more volatile compared to ACRX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs AYTU Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, AYTU has a market cap of 14.1M. Regarding current trading prices, RMTI is priced at $1.17, while AYTU trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas AYTU's P/E ratio is -1.54. In terms of profitability, RMTI's ROE is -0.01%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, RMTI is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TXMD Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TXMD has a market cap of 13.7M. Regarding current trading prices, RMTI is priced at $1.17, while TXMD trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TXMD's P/E ratio is -6.24. In terms of profitability, RMTI's ROE is -0.01%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, RMTI is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs COSM Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, COSM has a market cap of 13.7M. Regarding current trading prices, RMTI is priced at $1.17, while COSM trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas COSM's P/E ratio is -0.43. In terms of profitability, RMTI's ROE is -0.01%, compared to COSM's ROE of -0.51%. Regarding short-term risk, RMTI is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs TLPH Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, TLPH has a market cap of 10.5M. Regarding current trading prices, RMTI is priced at $1.17, while TLPH trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas TLPH's P/E ratio is -1.16. In terms of profitability, RMTI's ROE is -0.01%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, RMTI is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs AGRX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, RMTI is priced at $1.17, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas AGRX's P/E ratio is -0.89. In terms of profitability, RMTI's ROE is -0.01%, compared to AGRX's ROE of +0.93%. Regarding short-term risk, RMTI is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs IMCC Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, IMCC has a market cap of 10.4M. Regarding current trading prices, RMTI is priced at $1.17, while IMCC trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas IMCC's P/E ratio is -2.43. In terms of profitability, RMTI's ROE is -0.01%, compared to IMCC's ROE of -0.79%. Regarding short-term risk, RMTI is less volatile compared to IMCC. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs SBFMW Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, SBFMW has a market cap of 9.1M. Regarding current trading prices, RMTI is priced at $1.17, while SBFMW trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas SBFMW's P/E ratio is -0.13. In terms of profitability, RMTI's ROE is -0.01%, compared to SBFMW's ROE of -0.21%. Regarding short-term risk, RMTI is less volatile compared to SBFMW. This indicates potentially lower risk in terms of short-term price fluctuations for RMTI.
RMTI vs EVOK Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, EVOK has a market cap of 9.1M. Regarding current trading prices, RMTI is priced at $1.17, while EVOK trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas EVOK's P/E ratio is -4.95. In terms of profitability, RMTI's ROE is -0.01%, compared to EVOK's ROE of -1.02%. Regarding short-term risk, RMTI is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs YCBD Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, YCBD has a market cap of 8.3M. Regarding current trading prices, RMTI is priced at $1.17, while YCBD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas YCBD's P/E ratio is 0.01. In terms of profitability, RMTI's ROE is -0.01%, compared to YCBD's ROE of -0.01%. Regarding short-term risk, RMTI is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs NLTX Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, RMTI is priced at $1.17, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas NLTX's P/E ratio is -0.28. In terms of profitability, RMTI's ROE is -0.01%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, RMTI is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.
RMTI vs BFRIW Comparison
RMTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RMTI stands at 44.3M. In comparison, BFRIW has a market cap of 7.9M. Regarding current trading prices, RMTI is priced at $1.17, while BFRIW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RMTI currently has a P/E ratio of -129.50, whereas BFRIW's P/E ratio is -0.08. In terms of profitability, RMTI's ROE is -0.01%, compared to BFRIW's ROE of -2.16%. Regarding short-term risk, RMTI is more volatile compared to BFRIW. This indicates potentially higher risk in terms of short-term price fluctuations for RMTI.